Applications are invited for 14 ESRs (Early Stage Researchers) funded by the Marie-Sklodowska-Curie Innovative Training Network Hyperboost (Hyperthermia boosting the effect of Radiotherapy; project 955625) within the European Horizon 2020 Programme. Hyperboost is an international consortium of high-profile universities, research institutions and companies located in Switzerland, Denmark, Germany, Sweden, Italy and the Netherlands. We are looking for 14 PhD candidates.
HyperBoost aims to deliver a new generation of creative and entrepreneurial professionals with the skills and expertise to coordinate, develop, apply and optimise advanced multi-modality cancer treatments. In HyperBoost we will develop an advanced personalised treatment planning platform for hyperthermia combined with radiotherapy based on extensive preclinical and clinical data. To this end HyperBoost amalgamates an exceptional faculty, constitutes a role model for diversity, and represents a unique blend of international leaders in their fields, as well as excellent investigators at various career stages.
HyperBoost is a training network in the field of oncology, covering all disciplines. HyperBoost will train 14 ESRs (PhD candidates) in multidisciplinary innovative scientific preclinical, clinical, technical and complementary skills, seconded to private / public / academic sectors in multiple countries and build relations with potential future employers.
Interest in multi-modality cancer treatments is rising, and there is an urgent need for highly skilled multi-disciplinary researchers and professionals capable of translating complex clinical questions into multi-modality oncological approaches, in turn leading to more effective clinical applications, benefitting more patients and boosting business opportunities for small/medium enterprise across Europe.
Thermal treatments using hyperthermia at 40-44°C have profound biological and clinical effects and are successfully used as cancer treatment combined with radiotherapy and chemotherapy. Development of an advanced personalised treatment planning platform for hyperthermia is at the core of HyperBoost ("Hyperthermia boosting the effect of Radiotherapy").
HyperBoost is designed to train and equip early stage researchers with transferable, multi-disciplinary skills essential in high-end biomedical research and engineering, clinical hyperthermia and translational oncology. The HyperBoost training network will involve all relevant sectors (hospitals, academia, industry, patients) and integrate all disciplines: clinical and pre-clinical studies, physics, bioinformatics, computer science, statistics, mathematics, ICT infrastructure, ethical and societal aspects.
We accept applications from Early Stage Researcher (ESR) with less than 4 years research experience and no doctoral degree.
Please read carefully the minimum eligibility criteria listed on the website.
We look for ESRs with a master degree in relevant disciplines, including biology, physics, biostatistics, clinical epidemiology, medicine, medical/electrical engineering, information science. Precise requirements can be found with the 14 job descriptions on the website. The candidates should have a keen interest in innovative multidisciplinary research in the field of oncology, and in translation of preclinical research into better clinical results.
All applications proceed through the on-line recruitment portal on the HyperBoost website. Please click the ‘apply now’ button to go there.
|Title||14 positions for PhD students in the EU Horizon 2020 Marie Skłodowska-Curie MSCA-ITN project|
|Published||September 7, 2020|
|Application deadline||October 16, 2020|
|Job types||PhD  |
|Fields||Biostatistics,   Biomedicine,   Cancer Research,   Clinical Sciences,   Radiology,   Oncology,   Epidemiology  |